For the six months ended June 2026, consolidated net sales were 12,659,500,000 yen, operating income was 1,679,828 thousand yen, and net income attributable to owners of the parent was 1,112,433 thousand yen. Year-over-year, net sales increased by 3.2%, operating income decreased by 15.2%, and net income decreased by 22.2%. Announced the integration with D VX to take place on September 1, 2026. For the six months ending June 2027, the outlook is not yet determined. Dividend at year-end: 80 yen per share; dividend policy for the current term is undecided due to the integration. Segments are three: medical devices, SPD, and nursing care products. Equity ratio improved to 28.0%. Cash and cash equivalents at period-end: 2,590 million yen. The financial summary is unaudited.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2689","jir_company_name":"Orba HealthCare Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2689-20260812-01.pdf","jir_short_summary":"For the six months ended June 2026, consolidated net sales were 12,659,500,000 yen, operating income was 1,679,828 thousand yen, and net income attributable to owners of the parent was 1,112,433 thousand yen. Year-over-year, net sales increased by 3.2%, operating income decreased by 15.2%, and net income decreased by 22.2%. Announced the integration with D VX to take place on September 1, 2026. For the six months ending June 2027, the outlook is not yet determined. Dividend at year-end: 80 yen per share; dividend policy for the current term is undecided due to the integration. Segments are three: medical devices, SPD, and nursing care products. Equity ratio improved to 28.0%. Cash and cash equivalents at period-end: 2,590 million yen. The financial summary is unaudited.","jir_summary":"### Section heading\nOverview of earnings: For the six months ended June 2026, consolidated net sales were 12,659,500 thousand yen (up 3.2% YoY), but operating income declined to 1,679,828 thousand yen (down 15.2% YoY) and net income attributable to owners of the parent was 1,112,433 thousand yen (down 22.2% YoY). While pursuing price negotiations and cost-control initiatives in the mid-term plan, increases in raw material and logistics costs, rising labor costs, and integration-related expenses weighed on results. The company announced a management integration with D VX scheduled for September 2026, and plans to transition to the new post-integration structure.\n\n### Section 2 heading\nOutlook: For the next period, the group-wide earnings outlook after the D VX integration will be disclosed as soon as it is determined. Segments focus on three divisions: medical devices, SPD, and nursing care products, with efforts in logistics, IT investment, human resource development, and BCP strengthening. The dividend policy remains to keep the 80 yen per share in this term, but will be decided based on the integration situation.","jir_financial_highlights":"Sales: 126,595,620\u5343\u5186 (\u524d\u5e74\u540c\u671f\u6bd43.2\uff05\u5897)\nOperating income: 1,679,828\u5343\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b315.2\uff05\u6e1b)\nNet income attributable to owners of the parent: 1,112,433\u5343\u5186 (\u524d\u5e74\u540c\u671f\u6bd4\u25b322.2\uff05\u6e1b)\nEquity ratio: 28.0% (\u524d\u5e74\u540c\u671f\u6bd4+1.3\u30dd\u30a4\u30f3\u30c8)\nCash and cash equivalents at period-end: 2,590\u767e\u4e07\u5186 (\u524d\u671f\u672b3,420\u767e\u4e07\u5186\u2192\u25b3830\u767e\u4e07\u5186)\nDividends: \u671f\u672b1\u682a80\u5186 (2025\u5e74\u5ea6\u5b9f\u7e3e80\u5186\u30012026\u5e74\u5ea6\u672b\u306f\u672a\u5b9a)","jir_category":"","jir_hashtags":"#OrbaHealthCareHoldings, #FinancialSummary, #ManagementIntegration","jir_key_figures":"126,595,620\u5343\u5186: Sales\uff082026\u5e746\u6708\u671f\uff09\n1,679,828\u5343\u5186: Operating income\uff08\u524d\u5e74\u540c\u671f\u6bd4\u25b315.2\uff05\u6e1b\uff09\n1,112,433\u5343\u5186: Net income attributable to owners of the parent\uff08\u524d\u5e74\u540c\u671f\u6bd4\u25b322.2\uff05\u6e1b\uff09","jir_meta_title":"\u3010Orba HealthCare Holdings\u30112026 June Term Financial Summary\uff5cSales 1,266.5 billion yen, Integration Project Announced","jir_meta_description":"Orba HealthCare Holdings' six-month period ended June 2026: sales 12,659,620 thousand yen, operating income 1,679,828 thousand yen, net income 1,112,433 thousand yen. With the management integration with D VX scheduled for September 1, details on outlook are provided.","jir_og_title":"\u3010Orba HealthCare Holdings\u30112026 June Term Financial Summary\uff5cIntegration on the horizon","jir_og_description":"Orba HealthCare Holdings' financial summary. Sales increased year-over-year, but profits declined. Integration with D VX planned for September.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58611,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-102408","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n